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Sampling trabecular meshwork using
TrabEx+
Vipul Ramjiani1*, Hardeep-Singh Mudhar2, Thomas Julian1,3 and Graham Auger1
Abstract
Background: To report sampling of the trabecular meshwork using the TrabEx+ (MicroSurgical Technology,
Redmond, Washington, USA) device in ab interno trabeculectomy. Specifically, this series focusses upon
preservation of the trabecular meshwork architecture for assessment of glaucomatous features using common
histopathological techniques.
Patients: This series features six glaucomatous eyes undergoing TrabEx+ with or without cataract surgery. Three
patients had primary open angle glaucoma and the remaining had pigment dispersion glaucoma, ocular
hypertension or uveitic glaucoma. Four eyes had simultaneous cataract surgery.
Methods: Trabecular meshwork was excised using the TrabEx+ device and retrieved using vitreoretinal forceps. The
samples were then processed into formalin-fixed paraffin-embedded 4 micron tissue segments and stained with
haematoxylin and eosin, periodic acid–Schiff and elastin Van Gieson. Collagen IV was labelled using
immunohistochemistry for the purpose of identifying the basement membrane of trabecular beams.
Results: Presence of trabecular meshwork was confirmed in five of the six samples taken. One of six samples
consisted of blood only, but this was expected following early termination of the procedure due to patient
restlessness. In the five positive cases trabecular beams with associated trabecular meshwork cells were identified
on hematoxylin-eosin and periodic acid–Schiff staining. The beams retained their lamellar structure. The basement
membrane underlying the trabecular cells was evident in three specimens, whilst two specimens were of
insufficient size for collagen IV labelling.
Conclusions: This case series illustrates that TrabEx+ can be utilised to successfully retrieve trabecular meshwork
samples with sufficient architectural perseveration of the tissue to enable histopathological and laboratory analysis.
Keywords: TrabEx+, Trabecular meshwork, Ab interno trabeculectomy, Histology, Tissue sampling
© The Author(s). 2021 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License,
which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give
appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if
changes were made. The images or other third party material in this article are included in the article's Creative Commons
licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons
licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain
permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the
data made available in this article, unless otherwise stated in a credit line to the data.
* Correspondence: vipul.ramjiani@nhs.net
1Department of Ophthalmology, Sheffield Teaching Hospitals NHS
Foundation Trust, Royal Hallamshire Hospital, Glossop Rd, England S10 2JF
Sheffield, UK
Full list of author information is available at the end of the article
Ramjiani et al. BMC Ophthalmology          (2021) 21:138 
https://doi.org/10.1186/s12886-021-01895-6
Précis
In this case series, it has been demonstrated that the
TrabEx + has the capacity to successfully retrieve archi-
tecturally preserved samples of trabecular meshwork
during ab interno trabeculectomy.
Background
TrabEx+ (MicroSurgical Technology, Redmond, Wash-
ington, USA) is a minimally invasive glaucoma surgery
device, formally known as Goniotome + I/A (Neomedix
USA). The design includes a serrated dual blade which
simultaneously lifts and excises a strip of trabecular
meshwork (TM). An ab interno approach is adopted
though a temporal clear corneal incision. Up to 180 de-
grees of nasal TM is excised to facilitate aqueous out-
flow. The dual blade is supported by irrigation and
aspiration (IA) ports which enables maintenance of a
deep, stable and clear anterior chamber for better angle
visualisation during surgery[1]. An example of another
ab interno trabeculectomy device with IA support is the
Trabectome (MicroSurgical Technology), however this
device cannot be utilised to harvest TM due to its abla-
tive function. The irrigation and aspiration support dif-
ferentiates these two devices from other ab interno
trabeculectomy instruments which require viscoelastic to
enable gonioscopic view. Viscoelastic-dependent devices
include standalone TrabEx (Microsurgical Technology)
and Kahook Dual Blade (KDB) (New World Medical,
Rancho Cucamonga, California, USA). All four proce-
dures can be performed with or without cataract sur-
gery. The outcomes of TrabEx + procedures are yet to be
published; however our results (unpublished) show that
they resemble the outcomes of Trabectome [2].
These four goniectomy devices were developed to ad-
dress outflow resistance at the TM as a driver in primary
open angle glaucoma (POAG). Although the pathogen-
esis of outflow resistance remains poorly understood,
many changes in the structure of the TM have been doc-
umented in glaucomatous eyes. Pathological findings de-
scribed in the literature include progressive TM cell loss,
hyperpigmentation and extracellular matrix compos-
itional change in relation to glycosaminoglycans and the
elastic fibre network[3–9]. There is ongoing need for
in vivo and in vitro studies of the outflow pathway in
order to drive targeted advances in the medical and sur-
gical treatment of glaucoma. The majority of histopatho-
logical studies of the TM and Schlemm’s canal (SC) are
from cadaver specimens and ab externo trabeculectomy
specimens. More recently, KDB has been shown to har-
vest TM with good yield[10]. TrabEx + includes a dual
blade system similar to KDB and so also has the poten-
tial to harvest tissue, therefore enabling this device to re-
trieve free TM for histological analysis. The support of
IA in the TrabEx + has the added benefit of improved
angle visualisation during tissue excision when com-
pared to the KDB, thus maximising degrees of TM exci-
sion and minimising inadvertent tissue damage[1]. An
ophthalmic viscosurgical device (OVD) is used thereafter
to maintain anterior chamber depth whilst TM is re-
moved with forceps.
To the best of our knowledge, there is no publication
addressing histological analysis of samples derived from
TrabEx+. In this study, we describe a series of cases
which underwent TrabEx + and the related histopatho-
logical findings. The primary outcome of this research
was assessment of the preservation of the TM architec-
ture after sampling. Secondary outcomes included the
description of histopathological findings and a brief




This study was a non-interventional consecutive case
series of six glaucomatous eyes undergoing TrabEx +
with or without cataract surgery. All patients consented
to involvement in the study. Surgeries were performed
between June 2019 and September 2019. Tissue samples
were collected from all eyes and sent for histopatho-
logical assessment to the National Specialist Ophthalmic
Pathology Service (NSOPS) laboratory in Sheffield UK.
Clinical assessment
Preoperative demographic information, diagnosis, past
ocular surgery and previous laser trabeculoplasty history
if applicable were collected. The Hodapp-Anderson-
Parrish criteria for glaucoma severity were calculated for
each eye accompanied by the Humphrey visual field
mean deviation [11]. Eyes with ocular hypertension
(OHT) had no severity grading. Intraocular pressures
and the number of IOP lowering medications were col-
lected before TrabEx + and at the latest follow up. Mean
and standard deviations are documented for continuous
variables.
Surgical procedure
All surgeries were performed by one glaucoma surgeon,
in one U.K. hospital trust. During surgery, the patients
head is rotated 30 degrees away from the surgeon and
the operating microscope is titled towards the surgeon.
A temporal 1.8mm clear corneal incision is made. A
goniolens is held in contact with the cornea with the aid
of a viscoelastic coupling agent. The TrabEx + handpiece
is inserted through the corneal wound and irrigation is
engaged. The tip is advanced across the anterior cham-
ber. The dual blades enter the nasal SC. TM is excised
up to 90 degrees in a counter-clockwise direction. The
dual blades are disengaged from SC, rotated 180 degrees,
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and reengaged with SC at the initial contact point. TM
is excised up to 90 degrees in a clockwise direction. Two
free ends of TM should be visible in the anterior cham-
ber. The TrabEx + handpiece is withdrawn from the eye.
Viscoelastic is injected into the AC. The free strips of
TM are retrieved with vitreoretinal forceps. The TM tis-
sue was placed into a formalin pot and sent for
histology.
If eyes had simultaneous cataract surgery, this was per-
formed prior to TrabEx+. Miochol was injected at the
end of cataract surgery and the main wound was closed
with one 10 − 0 nylon suture. A second 1.8mm wound
anterior to the cataract wound was created for the Tra-
bEx + handpiece and the procedure proceeds as previ-
ously described. Creating a second smaller wound for
the TrabEx + handpiece minimises reflux from the AC
leading to instability in AC depth compromising gonio-
scopic surgery.
Histological preparation
The trabecular meshwork specimens were fixed over-
night in 10 % buffered formalin, processed to paraffin
blocks and 4 micron sections cut. The samples under-
went routine staining with haematoxylin and eosin
(H&E), periodic acid-Schiff (PAS), and elastin Von Gie-
son (EVG). Collagen IV was labelled in order to confirm
the basement membrane of trabecular beams. Immuno-
histochemistry (IHC) for collagen IV (Clone CIV 22
Manufacturer Dako (Agilent) concentrate dilution 1:400)
was completed as follows: Target Retrieval was carried
out with EnVision FLEX TRS, Low pH (Dako Omnis) at
97 °C for 30 min incubation, followed by Primary Anti-
body incubation for 20 min. Then the endogenous en-
zyme block was carried out with EnVision FLEX
Peroxidase blocking reagent (Dako Omnis) for 3 min,
followed by labelled polymer, EnVision FLEX/HRP
(Dako Omnis) for 20 min. Finally, substrate chromogen:
EnVision FLEX Substrate Working Solution (Dako
Omnis) was performed for 5 min before counterstaining
with hematoxylin (Dako Omnis) for 3 min.
Results
Clinical context
The mean age was 69.8 ± 12.3 years. The mean time from
diagnosis to surgery was 97.26 ± 104.54 months. Three pa-
tients had POAG and the remaining had pigment dispersion
glaucoma (PDS), secondary uveitic glaucoma or OHT. Four
eyes had simultaneous cataract surgery. Two eyes were pseu-
dophakic at the time of TrabEx+. One eye had argon laser
trabeculoplasty 24 years prior to TrabEx+ (Table 1). No
other surgical procedures were performed on the eyes prior
to TrabEx+. Pre-operative mean IOP and medications were
30.17mmHg (± 7.68mmHg) and 1.83 (± 1.72) respectively.
No washout period was performed. Post-operative mean
IOP and medications were 22.83mmHg (± 8.80mmHg) and
1.50 (± 1.76) respectively. The mean interval between oper-
ation and latest IOP and medication count follow up was 6.7
months (± 4.23). Thus, changes in mean IOP were −
7.33mmHg (p = 0.15), equivalent to a 24.31% reduction; and
medications were reduced by -0.33 (p= 0.75). Eye number 1
had no change in IOP and remained uncontrolled at
38mmHg. She was intolerant of any drops and was subse-
quently listed for trabeculectomy. Post trabeculectomy the
eye remains controlled at 19mmHg off drops.
The process of harvesting tissue did not lead to com-
plications but invariably added complexity and time to
the procedure. This was due to blood reflux from the
collector channels obscuring the angle view and patients
becoming restless, presumably secondary to fluctuations
in anterior chamber depth and extended surgical time.







Laser Trabeculoplasty Type /









OHT - N/A 72 n/a -2.09
2 F 70–
80
Uveitic + N/A 39 Early -3.17
3 F 70–
80
POAG + N/A 30 Early -2.51
4 F 70–
80
POAG + N/A 119 Early -4.22
5 F 80–
90
POAG + N/A 26 Moderate -7.51
6 M 60–
70
PDG - ALT / 24 298 Moderate -7.68
POAG primary open angle glaucoma, PDG pigment dispersion glaucoma, OHT Ocular Hypertension, ALT argon laser trabeculoplasty, HVF MD Humphrey visual field
mean deviation
aDetermined using the Hodapp-Anderson-Parrish criteria
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Histological findings
Trabecular meshwork was confirmed on histology in five
of the six specimens taken (Table 2). In the five positive
cases trabecular beams with associated TM cells were
identified on H&E and PAS staining (Fig. 1 a, b). The
beams retained their lamellar structure. Some of the
samples were distorted which was attributed to either in-
strumental handling in theatre or in the histopathology
laboratory. The specimen from eye number 2 showed
blood only and no evidence of trabecular meshwork.
Table 2 Histology characteristics of trabecular meshwork samples derived from TrabEx+
Eye number Structural Preservation of Trabecular Beams Elastin with EVG staining Collagen 4 present
1 Yes No n/a
2 Acellular n/a n/a
3 Yes Yes Yes
4 Yes Yes Yes
5 Yes No n/a
6 Yes No Yes
EVG elastin Von Gieson, n/a insufficient sample
Fig. 1 a-Haematoxylin and Eosin (H&E) stained section of trabecular meshwork. The arrow points to compressed trabecular beams. The asterisk
indicates the spaces created by dispersion of the trabecular beams from surgical sampling. b-Periodic acid-Schiff (PAS) stain of the trabecular
meshwork. The beams are stained pink. The arrow points to a layer of darker pink material on the trabecular beams indicating trabecular
meshwork cell basement membrane. c-PAS stain showing the presence of Descemet’s membrane exhibiting Hassall-Henle excrescences. d-H&E
stained trabecular meshwork from eye number 6 with pigment dispersion glaucoma. Note the dark brown pigment deposited on the trabecular
beams (arrow). e-Elastin Von Gieson stain of trabecular meshwork showing patchy elastin presence (arrows point to black linear elastin). f-
Collagen IV immunohistochemistry. The arrow points to tram track linear staining (brown-positive) over the beams.
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The histology outcome was predicted by the surgeon as
tissue sampling was abandoned prematurely when the
patient became restless. Three out of the five positive
specimens demonstrated the presence of erythrocytes,
an expected consequence of the surgical technique.
There were two notable findings in the study cohort.
Firstly, eye number 4 showed a localised area of Desce-
met’s membrane with Hassall-Henle excrescences asso-
ciated with the adjacent TM (Fig. 1 c). At the time of
surgery incorporation of corneal tissue was not noted
and is unavoidable in some instances due to variation in
its posterior extension. At follow up no corneal compli-
cations were seen. Secondly, eye number 6 with PDG
showed dense pigment in every trabecular meshwork
cell demonstrating their phagocytic capacity (Fig. 1d).
Many pigment granules were also seen on the trabecular
beams. All other TM specimens showed much less pig-
ment in TM cells, similar to non-glaucoma eyes.
Two specimens from POAG eyes showed evidence of
elastin with EVG staining (Fig. 1e). The remaining three
TM specimens did not express elastin. Collagen IV la-
belling was evident on the surface of trabecular beams in
three specimens, identifying the basement membrane
underlying the trabecular cells (Fig. 1 f). The other two
trabecular specimens were insufficient in size to perform
labelling.
Discussion
TrabEx + can harvest TM with preservation of its archi-
tecture. This was demonstrated by the presence of tra-
becular beams orientated in a lamellar fashion on
histology without compression or distortion. Dysfunc-
tion of the trabecular meshwork remains only partly
understood despite its major pathogenic role in open
angle glaucoma. Key observations have included accu-
mulation of extracellular matrix; TM cell loss; changes
in many glycosaminoglycan and protein profiles; and in-
creased TM rigidity[5–9]. TrabEx + can harvest TM
specimens for applications in immunohistochemistry,
proteomics, mass spectrometry, genetic analyses and cell
cultures. Tissue studies will direct advances in therapy,
and potentially add to the repertoire of medications
which will modulate TM structure and function, with
Rho kinase inhibitors being the first and only drug class
to accomplish this at present[12]. The preservation of
tissue integrity in the sampling of trabecular meshwork
is a pre-requisite to in-vitro studies and TrabEx + is a
suitable non-destructive means of harvesting tissue.
Considering the small sample size and absent control
group, deriving conclusions about glaucomatous features
on histopathology would be of limited use in this study.
Controls derived from non-glaucomatous donor eyes
with larger sample numbers would allow meaningful dif-
ferences to be investigated including variation between
glaucoma severities. There are some histopathological
findings to note. The absence of elastin in three TM
specimens may be due to localisation of elastin in cor-
neoscleral TM which was not included in the specimen.
The small nature of the samples can limit investigations,
as illustrated with Collagen IV labelling.
.
This study did not specifically address yield of TM re-
trieval. Nevertheless, it is important to note that tissue
retrieval had to be abandoned in some cases of TrabEx+.
This often is due to intra-operative anterior chamber
haemorrhage, an expected consequence of surgery which
obscures angle view. IA maintains good gonioscopic
view whilst the TM is stripped. This will facilitate
greater degrees of TM removal and minimise inadvert-
ent sample disruption. View thereafter, similar to KDB
and TrabEx, is maintained with viscoelastic during tissue
retrieval with forceps. During this process the viscoelas-
tic can escape the eye. In such circumstances, the anter-
ior chamber will depressurise and refill with blood. AC
washout and more viscoelastic injection are necessary
and may need repetition. This will prolong the operation
compromising the patient’s tolerance thus necessitating
abandoning tissue sampling. Using the aspiration port of
the TrabEx + to harvest tissue is a potential method to
avoid these challenges. Thereafter, centrifugation of the
irrigation fluid could concentrate the sample for hist-
ology. Although all material aspirated including blood
and other debris would be condensed together which
may obscure and distort the fragile TM architecture.
This has not been attempted yet. In both methods of tis-
sue harvesting, addressing the percentage yield would
need to be addressed in future studies.
TrabEx + reduced both IOP and number of drop treat-
ments, but the change was not statistically significant
(P > 0.05) for either. The cohort size was poorly powered
to measure these changes. However, this was not the
main objective of this study and clinical outcomes will
be published in future work. It is worth mentioning the
poor response of eye number 1. The patient was noted
to have dysmorphic features and anomalous anterior
segment structures. It is likely that a significant propor-
tion of outflow resistance was distal to the TM, and the
eye’s normal TM histology would support this argument.
The poor outcome for eye 1 skews the overall IOP out-
comes of this small cohort giving large IOP intervals;
however the overall IOP outcome are still promising
with an average 7.33mmHg reduction in IOP.
The small sample size, absence of control group, and
absence of blinding were limitations of this study. Future
large cohort studies would allow for correlation between
clinical data (i.e. severity, drug therapy, prior laser treat-
ment) and histopathological findings. A natural conse-
quence of TrabEx + derived specimens is the loss of
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adjacent supporting tissue which could limit studies on
TM function. The risk of tissue distortion or destruc-
tion, not demonstrated in this study, still remains a po-
tential risk to larger cohort studies. The small and fragile
nature of the specimens may be insufficient to perform
particular laboratory studies and the in vitro behaviour
of TM cells does not always replicate in vivo
behaviour[13].
Conclusions
TrabEx + is a viable means to harvest trabecular mesh-
work with tissue preservation allowing histopathological
and further laboratory studies.
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